122 related articles for article (PubMed ID: 25403925)
1. Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice.
Field K; Shapiro J; Wong HL; Tacey M; Nott L; Tran B; Turner N; Ananda S; Richardson G; Jennens R; Wong R; Power J; Burge M; Gibbs P
Intern Med J; 2015 Mar; 45(3):267-74. PubMed ID: 25403925
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
[TBL] [Abstract][Full Text] [Related]
3. Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: results from the South Australian Metastatic Colorectal Cancer Registry.
McNeill D; Karapetis CS; Price TJ; Meagher P; Piantadosi C; Quinn S; Roder D; Padbury R; Maddern G; Townsend A; Jayawardana MW; Roy AC
Intern Med J; 2021 Jan; 51(1):69-77. PubMed ID: 31985128
[TBL] [Abstract][Full Text] [Related]
4. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
5. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
Heinemann V; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Stauch M; Scheithauer W; Hielscher J; Scholz M; Müller S; Link H; Niederle N; Rost A; Höffkes HG; Moehler M; Lindig RU; Modest DP; Rossius L; Kirchner T; Jung A; Stintzing S
Lancet Oncol; 2014 Sep; 15(10):1065-75. PubMed ID: 25088940
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia.
Parakh S; Wong HL; Rai R; Ali S; Field K; Shapiro J; Wong R; Nott L; Gibbs P; Yip D
J Geriatr Oncol; 2015 Sep; 6(5):387-94. PubMed ID: 26190441
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
Kozloff M; Yood MU; Berlin J; Flynn PJ; Kabbinavar FF; Purdie DM; Ashby MA; Dong W; Sugrue MM; Grothey A;
Oncologist; 2009 Sep; 14(9):862-70. PubMed ID: 19726453
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort study.
Hurwitz HI; Bekaii-Saab TS; Bendell JC; Cohn AL; Kozloff M; Roach N; Mun Y; Fish S; Flick ED; Grothey A;
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):323-32. PubMed ID: 24686090
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.
Vatandoust S; Price TJ; Ullah S; Roy AC; Beeke C; Young JP; Townsend A; Padbury R; Roder D; Karapetis CS
Clin Colorectal Cancer; 2016 Mar; 15(1):32-6. PubMed ID: 26341410
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
11. A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels.
Ng SL; Burns WI; Snyder RD; Newnham GM; McLachlan SA; Liew D; Dowling AJ
Asia Pac J Clin Oncol; 2012 Jun; 8(2):172-9. PubMed ID: 22524576
[TBL] [Abstract][Full Text] [Related]
12. The effect of the public or private status of health care facility in acute coronary syndrome: data from Thai ACS Registry.
Hutayanon P; Sarakarn P; Buakhamsri A; Boonsom W; Yamwong S
J Med Assoc Thai; 2007 Oct; 90 Suppl 1():98-108. PubMed ID: 18431892
[TBL] [Abstract][Full Text] [Related]
13. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
14. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry.
Tomita Y; Karapetis CS; Roder D; Beeke C; Hocking C; Roy AC; Townsend AR; Padbury R; Maddern G; Price TJ
Aust J Rural Health; 2016 Apr; 24(2):85-91. PubMed ID: 26255652
[TBL] [Abstract][Full Text] [Related]
15. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
[TBL] [Abstract][Full Text] [Related]
16. Developing a national database for metastatic colorectal cancer management: perspectives and challenges.
Field K; Wong HL; Shapiro J; Kosmider S; Tie J; Bae S; Yip D; McKendrick J; Nott L; Desai J; Harold M; Lipton L; Stefanou G; Lim L; Parente P; Gibbs P
Intern Med J; 2013 Nov; 43(11):1224-31. PubMed ID: 23834128
[TBL] [Abstract][Full Text] [Related]
17. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
Zhao Z; Pelletier E; Barber B; Bhosle M; Wang S; Gao S; Klingman D
Curr Med Res Opin; 2012 Feb; 28(2):221-9. PubMed ID: 22171947
[TBL] [Abstract][Full Text] [Related]
18. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
19. Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals.
Morris M; Iacopetta B; Platell C
Med J Aust; 2007 Mar; 186(6):296-300. PubMed ID: 17371210
[TBL] [Abstract][Full Text] [Related]
20. Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice.
Lok SW; Wong HL; Kosmider S; Field K; Tie J; Desai J; Bae S; Tacey M; Skinner I; Jones I; Gibbs P
Asia Pac J Clin Oncol; 2014 Dec; 10(4):361-7. PubMed ID: 25131961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
